Luminex のパートナー

Zimmer Biomet provides testing services for infectious disease biomarker LDT immunoassays in synovial fluid.

• Application Area: Infectious Disease
• Target: Protein
• Primary Business: Testing Services
• Market Availability: Europe, United States
• Regulatory Classification: RUO

Perform multiple assays with a single sample using ZEUS AtheNA Multi-Lyte^® Test Systems for autoimmune and infectious diseases. Paired with the AtheNA Multi-Lyte^® Instrument, these multiplex, fluorescent, bead-based test systems offer a simple and efficient alternative to IFA and ELISA testing.

• Application Area: Autoimmune, Infectious Disease
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Through a dedicated focus on test innovation and workflow efficiency, Werfen is helping improve care for patients with autoimmune disease.

• Application Area: Autoimmune, HLA
• Target: Protein, Nucleic Acid
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Wakunaga Pharmaceutical researches and develops HLA typing reagents and anti-HLA antigen detecting reagents. The HLA typing reagents have been used for the transplantation donor registration in the Japanese bone marrow program and for the platelet donor registration in the Japanese Red Cross Society. In addition, the anti-HLA detecting reagents have been used for testing to determine the PC-HLA supply to patients in the Japanese Red Cross Society.

• Application Area: HLA
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD

Versiti Blood Center of Wisconsin diagnostic laboratories go beyond a test result, by providing support from their physicians and scientific directors. Their industry-leading, multidisciplinary diagnostic approach provides patient-centric insight in the fields of transfusion medicine, hematology, transplantation, and oncology.

• Target: Nucleic Acid, Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

• Application Area: Biomarker Screening, Companion Animal Testing, Infectious Disease
• Target: Protein
• Primary Business: Testing Services
• Market Availability: United States
• Regulatory Classification: RUO

Search the bead-based assays that utilize antibody-coated beads to measure and detect analytes of interest, and are ideal for use in an array of molecular research settings using magnetic, multiplex, singleplex, or custom immunoassays. You can also create custom multiplex RNA or DNA panels for use with the Invitrogen QuantiGene Plex Assay. All of these assays are compatible with all four xMAP^® instruments.

• Application Area: Autoimmune, Biomarker Screening, Cardiovascular, Hereditary Diseases, Neurological, Oncology, Vaccines
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: RUO

The FIDIS™ system, based on xMAP^® Technology, offers high-throughput analysis power and allows a simultaneous and specific detection of multiple analytes from the same sample in a single assay. Compared to the conventional IFA or ELISA format, the FIDIS technology and its automation on the Theralis™ platform allows the laboratory to perform analysis more rapidly, and at lower cost, than with conventional kit formats with optimum reliability.

• Application Area: Autoimmune
• Target: Protein
• Primary Business: Kits
• Market Availability: Global
• Regulatory Classification: IVD

Provides Research Use Only kits and testing services of arboviral infections and biothreat agents.

• Target: Protein
• Primary Business: Kits, Testing Services
• Market Availability: Global
• Regulatory Classification: RUO

The Tellgenplex^® HPV27 genotyping Assay is a human papillomavirus genotyping DNA detection kit for early screening of cervical cancer and to aid in the diagnosis of genital warts.

• Application Area: Oncology
• Target: Nucleic Acid, Protein
• Primary Business: Kits
• Market Availability: Asia-Pacific
• Regulatory Classification: IVD